Orbitofrontal cortex hypometabolism, medication overuse headache, substance abuse and migraine: Key pathophysiological issues [5]

Brain

Volumn 129, Issue 7, 2006, Pages

  Gupta, Vinod Kumar ^a  

^a Dubai eGovernment Dubai Police   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ABSTINENCE; ANALGESIC AGENT ABUSE; BRAIN FUNCTION; BRAIN METABOLISM; DOPAMINERGIC NERVE CELL; DRUG INDUCED HEADACHE; DRUG OVERDOSE; HEADACHE; HUMAN; LETTER; MIGRAINE; ORBITAL CORTEX; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESEARCH; SUBSTANCE ABUSE;

ANALGESICS; FRONTAL LOBE; HEADACHE; HUMANS; MIGRAINE DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 33745713890     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl119     Document Type: Letter

References (25)

1. Andrasik F. Psychologic, behavioral aspects of chronic headache. Neurol Clin 1990; 8: 961-76.
2. Anselmi B, Tarquini R, Panconesi A, de Leonardis V, Perfetto E, Piluso A, et al. Serum beta-endorphin increase after intravenous histamine treatment of chronic daily headache. Recenti Prog Med 1997; 88: 321-4.
3. Bignall J. Science of placebos. Lancet 1994; 344: 904.
4. Chen TC, Leviton A, Edelstein S, Ellenberg JH. Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 1987; 44: 1024-8.
5. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62: 1338-42.
6. Couturier EGM, Hering R, Steiner TJ. Weekend attacks in migraine patients: caused by caffeine withdrawal? Cephalalgia 1992; 12: 99-100.
7. Cowen MS, Adams C, Kraehenbuehl T, Vengeliene V, Lawrence AJ. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict Biol 2005; 10: 233-42.
8. Dhuna A, Pascual-Leone A, Belgrade M. Cocaine-related vascular headaches. J Neurol Neurosurg Psychiatry 1991; 54: 803-6.
9. Fumal A, Laureys S, Clemente LD, Boly M, Bohotin V, Vandenheede M, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2005; 129: 543-50.
10. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002; 346: 257-70.
11. Goldstein RZ, Alia-Klein N, Leskovjan AC, Fowler JS, Wang GJ, Gur RC, et al. Anger and depression in cocaine addiction: association with the orbitofrontal cortex. Psychiatry Res 2005; 138: 13-22.
12. Haas DC, Sheehe PR. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache. Headache 2004; 44: 1029-37.
13. Houezec JL, Benowitz NL. Basic and clinical psychopharmacology of nicotine. Clin Chest Med 1991; 12: 681-99.
14. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-90.
15. Lai M, Loi V, Pisano MR, Del Zompo M. Therapy of migraine by modulating dopamine hypersensitivity: its effect on mood and pain. Int J Clin Pharmacol Res 1997; 17: 101-3.
16. Lipton RB, Bigal ME. Chronic daily headache: is analgesic overuse a cause or a consequence? Neurology 2003; 61: 154-5.
17. Mathew NT, Tietjen GE, Lucker C. Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996; 16: 323-7.
18. Satel SL, Gawin FH. Migrainelike headache, cocaine use. JAMA 1989; 261: 2995-6.
19. Simons CT, Cuellar JM, Moore JA, Pinkerton KE, Uyeminami D, Carstens MI, et al. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke. Neurosci Lett 2005; 389: 71-6.
20. Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980; 20: 204-7.
21. Tepper SJ, Dodick DW. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Headache 2002; 42: 543-54.
22. Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 2005; 62: 1228-36.
23. Welch KMA. Migraine. A biobehavioral disorder. Arch Neurol 1987; 44: 323-7.
24. Wolf ME, Mosnaim AD. Phenylethylamine in neuropsychiatric disorders. Gen Pharmacol 1983; 14: 385-90.
25. Zwart J-A, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predicator of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003; 61: 160-4.